SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move!
ATIS 0.1000-47.4%Apr 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harry D. Kramer who wrote (1239)12/17/1997 9:41:00 PM
From: Marshall Teitelbaum  Read Replies (1) of 2205
 
Harry,

I don't really see regranex as being that big an issue, as their uses ultimately won't be totally competitive. Also, the approval for them at this point was far from a surprise, given the panel recommendation several months ago. Nevertheless, the earnings from regranex should be substantial for chir.(no hidden agenda here, as I happen to own some chir shares, also, but for far more reasons than regranex).

Regards,

Marshall
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News